IFP Advisors, Inc - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,829
-74.1%
200
-81.8%
0.00%
-100.0%
Q1 2023$14,795
+92368.8%
1,100
-2.3%
0.00%
Q4 2022$16
-99.5%
1,126
+914.4%
0.00%
Q3 2022$3,000
+50.0%
111
+8.8%
0.00%
Q2 2022$2,000
-33.3%
102
-49.5%
0.00%
Q1 2022$3,000
+50.0%
202
+102.0%
0.00%
Q4 2021$2,000
-33.3%
1000.0%0.00%
Q3 2021$3,000
-88.0%
100
-83.8%
0.00%
-100.0%
Q2 2021$25,000
-30.6%
616
-16.1%
0.00%0.0%
Q1 2021$36,000
+80.0%
734
+97.3%
0.00%0.0%
Q4 2020$20,000
+900.0%
372
+629.4%
0.00%
Q3 2020$2,000
-33.3%
51
-93.2%
0.00%
Q4 2018$3,000
-75.0%
750
-65.9%
0.00%
Q3 2018$12,000
-53.8%
2,200
+10.0%
0.00%
-100.0%
Q2 2018$26,000
+116.7%
2,000
+33.3%
0.00%0.0%
Q1 2018$12,0000.0%1,5000.0%0.00%0.0%
Q4 2017$12,000
-47.8%
1,500
-23.1%
0.00%0.0%
Q3 2017$23,000
-41.0%
1,950
-49.4%
0.00%
-50.0%
Q2 2017$39,000
+680.0%
3,850
+285.0%
0.00%
Q4 2016$5,000
+150.0%
1,000
+300.0%
0.00%
Q3 2016$2,0000.0%2500.0%0.00%
Q2 2016$2,000
-92.6%
250
-88.9%
0.00%
-100.0%
Q4 2015$27,0002,2500.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders